NCT05005949|Active Not RecruitingFDA Device
STOP Persistent AF PAS
STOP Persistent AF Post-Approval Study, a Sub-study to the Cryo Global Registry
Loading search results
STOP Persistent AF Post-Approval Study, a Sub-study to the Cryo Global Registry
Sponsor study identifier
observational
393
6 countries
17
Study Start
August 19, 2021
Actual (reported)Primary Completion
December 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The STOP Persistent AF Post Approval Study (PAS) is a prospective, global, multicenter, observational trial.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 29, 2021
Actual (reported)August 16, 2021
Actual (reported)August 19, 2021
Actual (reported)December 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Freedom from Atrial Fibrillation (AF) /Atrial Flutter (AFL) /Atrial Tachycardia (AT)
Estimate the 36-month freedom from Atrial Fibrillation (AF) /Atrial Flutter (AFL) /Atrial Tachycardia (AT) recurrence using the Arctic Front™ Cardiac Cryoablation Catheter System.
36 months
Freedom from Primary Safety Events
Estimate primary safety Adverse Event (AE) rates for cryoablation using the Arctic Front™ Cardiac Cryoablation Catheter System through 12-months.
12 months
Pulmonary vein isolation will be performed with the Arctic Front™ Cardiac Cryoablation Catheter System
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Subjects ≥ 18 years of age (or minimum age as required by local regulations) who have a recommendation for a pulmonary vein ablation with the Arctic Front™ Cardiac Cryoablation Catheter System may be approached regarding enrollment in this study.
Hartford Hospital
Hartford, Connecticut, 06102, United States
Cardiology Associates of Fairfield County
Stamford, Connecticut, 06905-5522, United States
BayCare Medical Group Cardiology
Clearwater, Florida, 33756, United States
Heart Rhythms Solutions
Davie, Florida, 33328, United States
Carle Foundation Hospital
Urbana, Illinois, 61801-2500, United States
Henry Ford Heart & Vascular
Detroit, Michigan, 48202-2608, United States
Spectrum Health Hospitals
Grand Rapids, Michigan, 49525-6427, United States
Khaldoun Tarakji, MD
Medtronic CAS Chief Medical Officer
393 participants (actual enrollment reported by the registry).
First Submitted
July 29, 2021
First Posted
August 16, 2021
Study Start
August 19, 2021
Actual (reported)Evaluation of the Phased Radio Frequency Ablation System
Contact the study team to confirm eligibility.
The Lindner Research Center
Cincinnati, Ohio, 45219-2906, United States
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas, 78705-1852, United States
Texas Health Research & Education Institute
Dallas, Texas, 75231, United States
Kepler Universitätsklinikum Med Campus III.
Linz, 4020, Austria
St. Vinzenz-Hospital Köln
Cologne, 50733, Germany
MVZ CCB Frankfurt und Main Taunus
Frankfurt am Main, 60431, Germany
Städtische Kliniken München GmbH - Klinikum Bogenhausen
München, 81925, Germany
Universitaria Pisana - Stabilimento di Cisanello
Pisa, 56124, Italy
Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodz
Lodz, 92-213, Poland
Liverpool Heart and Chest Hospital NHS Foundation Trust
Liverpool, L14 3PE, United Kingdom
Primary Completion
December 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 23, 2026
Record last verified: 2026-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: